Swine Flu: Current Status and Worst Case Scenario 16 comments
-
Font Size:
-
Print
- TweetThis
My pseudonym is accurate. I am a practicing physician. As such, I thought I'd share my understanding of the emergence of this new "Swine Flu" outbreak. I'm not a virologist, nor an infectious disease specialist, but the story of this influenza outbreak seems straightforward enough.
Influenza viruses seem to percolate and transmit in animal populations such as birds (avian) and pigs (swine), and periodically acquire the ability to infect people (such as SARS). Viruses tend to mutate quickly, and this is why the flu vaccines we make each year change: the viral antigens (proteins or glycoproteins that our immune system can "see") change from year to year. So the vaccines have to change too, enabling our immune system to "be ready" for the mutated viruses.
On the other hand, sometimes totally new viruses emerge: new combinations of swine, avian, and human influenza viruses. When this occurs, as is the case now, no previous vaccine or previous infection will afford any protection from the new virus. The "Swine Flu" virus now spreading around the globe is a unique and novel combination of swine, bird, and human viruses.
Unlike SARS, which was an avian virus with relatively low human to human transmission, this new virus appears to readily transmit between humans. Fortunately, except in Mexico, this new virus has, so far, produced a relatively mild case of the flu. There is only one report of a hospitalization in the U.S., but no serious illness. Also, no increase in ER visits has been noted, which the CDC and local health departments monitor closely.
Fortunately, researchers report that this new virus does respond to Relenza (GSK) and Tamiflu (RHHBY.PK and GILD), the two anti-viral compounds that are readily available and in mass production. That's the good news, so far. A new virus that has produced a mild case of the flu outside of Mexico, but, does transmit easily from person to person.
The fear. The worst case scenario and the one that keeps some infectious disease specialists up at night is the so-called Spanish Flu of 1918-1920. Researchers are still unclear about the precise orgins of the Spanish Flu Pandemic, but it appears to have originated as an avian virus, done some genetic recombination in pigs, and acquired the ability to infect and transmit between humans around 1918. The Spanish Flu virus was highly contagious, and had a mortality rate of up to 2% of infected individuals. A typical flu has a mortality rate of about 0.1%.
Unlike a typical flu outbreak, which tends to have the highest rates of mortality in the very old and the very young, the Spanish Flu had the highest mortality in those that were the healthiest: young adults. Researchers believe that the Spanish Flu killed by a couple of different mechanisms, including direct viral destruction of the lungs, or, triggering a massive immune response against the virus in the lungs, or, by setting the stage for a secondary bacterial infection after the virus itself had faded (there were no antibiotics in 1918).
The morbidity and mortality of the Spanish Flu of 1918 was somewhat obscured by World War I at the time. But the world wide pandemic's effects were staggering: estimates of up to 50 million dead world wide, with some localities all but wiped out, striking even the most isolated villages in the Arctic and the South Pacific.
The current "Swine Flu" of 2009 appears to transmit readily from person to person, but, except in Mexico, has been mild and without mortality. The fear is that the virus could mutate into a far more virulent and potentially lethal form. Indeed, the Spanish Flu of 1918 had a "first wave" in the spring of 1918, as a fairly mild viral inflection that was noted in just a few newspapers at the time. It re-emerged in the Fall of 1918 as perhaps the most lethal human to human infection in recorded history.
The closest historical analogy to the human toll of the Spanish Flu of 1918 is the Bubonic Plague that killed about 1 in 3 Europeans in the 1300s. The Plague was caused by a bacterium transmitted from rodents to humans via fleas. The Bubonic Plague is treatable with conventional antibiotics and makes an occasional appearance in real life, as well as medical school exams and television shows.
It is too early to be able to write off the current "Swine Flu" as a non-event. The "Mexican Flu of 2009" is a novel flu that has resulted in some mortality in Mexico, and is spreading rapidly throughout the world. Hopefully, the virulence of the virus will remain low, a vaccine will be manufactured and distributed, and there won't be much more to it than that.
Disclosures: None currently
Related Articles
|

























This article has 16 comments:
I didn't even know they did that sort of thing.
www.reuters.com/articl...
The kids in NY have aready started recoving. Saw a couple interviewed saying it was mild, compared to what's going on in Mexico.
Why is it less harsh here in US? My guess is better hygene and better nutrition than in Mexico.
The media can whip up a devastating worldwide crisis from the smallest piece of information. Every so often, such things happen, but not with the regularity we'd perceive just by watching the news.
I'll echo Papagiki - please keep us updated.
In most cases the media has no idea what it is talking about and either gravely overconfident or stupidly pessimistic.
I had done some reading about the Spanish Flu, and was keenly interested when scientists sequenced the viral genome, and published it. Some people including myself thought that was a mistake, for obvious "bio-terror" reasons.
The Mexican flu appears to be a different subtype. The key factor is the "virulence" or the severity of human illness. The virulence of this flu virus may have diminished since its formation in Mexico, as viral genomes can mutate rapidly. Lets hope it doesn't mutate to a more dangerous form before a vaccine is available.
Other than administering Relenza or Tamiflu there isn't much a doctor can do other than isolating the patient and that takes a lot of resources to isolate thousands of people which are not available here. Why the virus is more virulent here is an interesting question. I doubt that it has to do with nutrition but there must be some risk factor not recognized yet if indeed the virus is more virulent here.
The drug is in development and will soon be moving to phase 1.
The media is awash in an influenza frenzy. There is a good chance that swine flu will continue to spread. In a worst case scenario where it has infected millions, do you think people will care whether or not cures have gone through testing? This drug works, their data says so. If you want it please feel free to contact their investor relations.
Regardless of 'bad' scenarios, try to find me one other company that has an anti-viral NON VACCINE cure for influenza, and you will find none. Even CVM's cure works in a vaccine capability.
Vaccines rely on the antibodies of the person infected to fight them off while nano-viricides target the influenza virus specifically.
Vaccines only work for the strain they are specifically developed for, because antibodies that get created by the body are very specific, and though two flu may have similar symptoms and dangers, the antibodies distinguish them based on their different strains.
nano-Viricides and other anti-virals target the virus specifically regardless of what strain it is. Nano-Viricides however has the benefit of being the first drug that is effective against flu. Other anti-virals are not.
This company has NO DEBT. The company is not in any danger of going bankrupt because of the importance and the potential profit of their drugs. Investors could easily be sought out, and I'm sure a company with such potential is constantly doing just that, looking for investors.
The movement that this stock is currently taking is as a result to global attention to the influezna pandemic currently taking place. Though the volume may fade, the importance of finding cures for dangerous pandemics will become much more of a priority as time goes by. The estimation for damages of the swine flu pandemic so far half a trillion dollars according to bloomberg. Investing in the only company that bodes positive data for a cure to influenza is not only the smart and profitable move at this level, but it is a reflection of the entire movement of global health to protect and support companies that can in the future protect such half trillion damages from taking place at all, by curing the virus.
Disease spreads. More travel and commerce may makes it spread faster, but will not likely affect the range or mortality of the disease. No area of the world, no matter how remote, seemed to escape the Spanish Flu epidemic of 1918. Despite draconian public health regulations nearly everywhere.
Vaccines and antivirals seem the best, and less intrusive option.